ºÚÁÏÍø

ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
ºÚÁÏÍø

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ ºÚÁÏÍø Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

ºÚÁÏÍø Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Citations : 1089

Indexed In
  • CAS Source Index (CASSI)
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Genamics JournalSeek
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Publons
  • Euro Pub
  • ICMJE
Share This Page

Drug chart-quality improvement project

3rd Annual Congress on Hospital and Clinical Pharmacy

Madhuja Nath

National Health Service, UK

ScientificTracks Abstracts: Clin Pharmacol Biopharm

Abstract
Aim of audit: 1. To identify compliance of drug chart writing with BNF guidelines 2. To identify most common errors of prescription writingAction plan after 1st cycle: (APRIL-2022) � Messaging in the junior doctor�s group and highlighting the common errors according to our analysis and requesting them to incorporate the improvement in their day to day practice. � Discussing with colleagues about result of the analysis and encouraging them to minimize the error. Action plan after 2nd cycle Discussing about the analysis with the AMU doctors as majority of the patients are first admitted in the AMU so that the common errors of drug chart writing can be avoided. Emailing all doctors working in the trust to follow the standard guideline while writing the drug chart. JUNE-JULY SUMMARY This QIP comprises of 3 cycles. The action plans recommended have been practically implemented in day-to-day practice. The aim was to help maximum number of doctors follow the bnf guidelines while writing the drug charts, we believe we have been able to achieve that. The third cycle shows significant improvement as compared to the first cycle. The limitations that we need to bear in mind are there is always a scope for manual error, hence 100% improvements are difficult to obtain. The third cycle marks the end of this QIP.
Biography

I am Dr.Madhuja Nath , Graduated From Tver State Medical University Russia. After that I have worked in various multispeciality hospital, in both Public and private sector. Upon gaining significant amount of experience in India, I migrated to UK , now working in NHS as CT1 , in Department of Medicine.

International Conferences 2024-25
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top